Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Predictive Value of Fecal Calprotectin for the Outcome of Severe Alcoholic Hepatitis

NCT02808663 is registered in ClinicalTrials.gov with CHU de Reims as lead sponsor.

NCT NCT02808663
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02808663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Predictive Value of Fecal Calprotectin for the Outcome of Severe Alcoholic Hepatitis
Lead sponsor
CHU de Reims
Phase
Not applicable
Overall status
Completed
Start date
May 6, 2015
Completion date
February 1, 2017
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe alcoholic hepatitis